Press Releases Items Per Page 102550 News Category FinancialGeneral Year None20192018201720162015201420132012201120102009200820072006 New Research Collaboration between Nektar and Takeda to Explore Combination Cancer Therapy Approaches with NKTR-214, a CD122-Biased Agonist, and Five Takeda Cancer Therapy Compounds May 22, 2017 Nektar Therapeutics Announces Data Presentations at ASCO 2017 May 18, 2017 Nektar to Webcast Presentation at UBS Global Healthcare Conference 2017 in New York May 15, 2017 Nektar Therapeutics Reports Financial Results for the First Quarter of 2017 May 09, 2017 Nektar Appoints Brian L. Kotzin, M.D. as Head of Clinical Development for Nektar's Immunology Program May 03, 2017 Nektar to Announce Financial Results for the First Quarter of 2017 on Tuesday, May 9, 2017, After Close of U.S.-Based Financial Markets May 02, 2017 Nektar Therapeutics to Host Analyst & Investor Event at 2017 ASCO Annual Meeting Apr 20, 2017 Nektar Therapeutics Presents New Preclinical Data for its Immuno-Oncology Programs at the American Association for Cancer Research (AACR) Annual Meeting Apr 04, 2017 Nektar Therapeutics Initiates Clinical Study of NKTR-358, a First-in-Class Regulatory T Cell Stimulator, Being Developed for the Treatment of Immune and Inflammatory Disorders Mar 27, 2017 NKTR-181 Meets Primary and Secondary Endpoints in Phase 3 SUMMIT-07 Study in Chronic Pain Mar 20, 2017 Pagination First page « first Previous page ‹ previous … Page 4 Page 5 Page 6 Page 7 Current page 8 Page 9 Page 10 Page 11 Page 12 … Next page next › Last page last »